Gluten Degradation Using Recombinant Eurygaster Integriceps Prolyl Endoprotease: Implications for Celiac Disease

Overview

Journal Iran J Biotechnol

Specialty Biotechnology

Date 2024 Feb 12

PMID 38344704

Authors

Effat Noori

Mojgan Bandehpour

Mohammad Reza Zali

Bahram Kazemi

Affiliations

Soon will be listed here.

Abstract

Background: Celiac disease (CD) is a gluten-sensitive chronic autoimmune enteropathy. A strict life-long gluten-free diet is the only efficient and accepted treatment until now. However, maintaining a truly gluten-free status is both difficult and costly, often resulting in a social burden for the person. Moreover, 2 to 5 percent of patients fail to improve clinically and histologically upon elimination of dietary gluten. Therefore, novel therapeutic approaches, including gluten degrading enzymes, are an unmet need of celiac patients.

Objectives: To evaluate the function of sunn pest prolyl endoprotease for gluten and gliadin hydrolysis in vitro.

Materials And Methods: The spPEP was expressed as a recombinant protein in , and its catalytic activity was assessed by SDS-PAGE and RP-HPLC analyses.

Results: Production of a 100-kDa spPEP protein was confirmed by SDS-PAGE and western blot analysis. Also, we demonstrate that spPEP efficiently degrades gluten and α-gliadin (30-40 kDa) in vitro under conditions similar to the GI and is resistant to pepsin and trypsin.

Conclusion: The gathered data demonstrated that spPEP might be a novel candidate for Oral Enzymatic Therapy (OET) in CD and other gluten-related disorders.

References

Loberman-Nachum N, Sosnovski K, Segni A, Efroni G, Braun T, BenShoshan M . Defining the Celiac Disease Transcriptome using Clinical Pathology Specimens Reveals Biologic Pathways and Supports Diagnosis. Sci Rep. 2019; 9(1):16163. PMC: 6838157. DOI: 10.1038/s41598-019-52733-1. View

Mamone G, Addeo F, Chianese L, Di Luccia A, De Martino A, Nappo A . Characterization of wheat gliadin proteins by combined two-dimensional gel electrophoresis and tandem mass spectrometry. Proteomics. 2005; 5(11):2859-65. DOI: 10.1002/pmic.200401168. View

Shannahan S, Leffler D . Diagnosis and Updates in Celiac Disease. Gastrointest Endosc Clin N Am. 2016; 27(1):79-92. DOI: 10.1016/j.giec.2016.08.011. View

Jericho H, Sansotta N, Guandalini S . Extraintestinal Manifestations of Celiac Disease: Effectiveness of the Gluten-Free Diet. J Pediatr Gastroenterol Nutr. 2017; 65(1):75-79. DOI: 10.1097/MPG.0000000000001420. View

Piper J, Gray G, Khosla C . Effect of prolyl endopeptidase on digestive-resistant gliadin peptides in vivo. J Pharmacol Exp Ther. 2004; 311(1):213-9. DOI: 10.1124/jpet.104.068429. View

Veeraraghavan G, Leffler D, Kaswala D, Mukherjee R . Celiac disease 2015 update: new therapies. Expert Rev Gastroenterol Hepatol. 2015; 9(7):913-27. DOI: 10.1586/17474124.2015.1033399. View

Gass J, Ehren J, Strohmeier G, Isaacs I, Khosla C . Fermentation, purification, formulation, and pharmacological evaluation of a prolyl endopeptidase from Myxococcus xanthus: implications for Celiac Sprue therapy. Biotechnol Bioeng. 2005; 92(6):674-84. DOI: 10.1002/bit.20643. View

Moreno Amador M, Arevalo-Rodriguez M, Duran E, Martinez Reyes J, Sousa Martin C . A new microbial gluten-degrading prolyl endopeptidase: Potential application in celiac disease to reduce gluten immunogenic peptides. PLoS One. 2019; 14(6):e0218346. PMC: 6597064. DOI: 10.1371/journal.pone.0218346. View

Every D . General proteinase assay by formation of SDS-protein gels of proteolyzed substrate proteins. Anal Biochem. 1991; 197(1):208-12. DOI: 10.1016/0003-2697(91)90380-c. View

10.

Hosseininaveh V, Bandani A, Hosseininaveh F . Digestive proteolytic activity in the Sunn pest, Eurygaster integriceps. J Insect Sci. 2010; 9:1-11. PMC: 3011966. DOI: 10.1673/031.009.7001. View

11.

Gass J, Khosla C . Prolyl endopeptidases. Cell Mol Life Sci. 2006; 64(3):345-55. PMC: 11138450. DOI: 10.1007/s00018-006-6317-y. View

12.

Caputo I, Lepretti M, Martucciello S, Esposito C . Enzymatic strategies to detoxify gluten: implications for celiac disease. Enzyme Res. 2010; 2010:174354. PMC: 2963796. DOI: 10.4061/2010/174354. View

13.

Yoosuf S, Makharia G . Evolving Therapy for Celiac Disease. Front Pediatr. 2019; 7:193. PMC: 6530343. DOI: 10.3389/fped.2019.00193. View

14.

Gianfrani C, Camarca A, Mazzarella G, Di Stasio L, Giardullo N, Ferranti P . Extensive in vitro gastrointestinal digestion markedly reduces the immune-toxicity of Triticum monococcum wheat: implication for celiac disease. Mol Nutr Food Res. 2015; 59(9):1844-54. DOI: 10.1002/mnfr.201500126. View

15.

Liu Y, Lee C, Hsu J, Leu W, Meng M . Efficient Hydrolysis of Gluten-Derived Celiac Disease-Triggering Immunogenic Peptides by a Bacterial Serine Protease from . Biomolecules. 2021; 11(3). PMC: 8002681. DOI: 10.3390/biom11030451. View

16.

Helmerhorst E, Wei G . Experimental Strategy to Discover Microbes with Gluten-degrading Enzyme Activities. Proc SPIE Int Soc Opt Eng. 2015; 9112. PMC: 4477194. DOI: 10.1117/12.2058730. View

17.

Dieli-Crimi R, Cenit M, Nunez C . The genetics of celiac disease: A comprehensive review of clinical implications. J Autoimmun. 2015; 64:26-41. DOI: 10.1016/j.jaut.2015.07.003. View

18.

Darkoh C, El-Bouhssini M, Baum M, Clack B . Characterization of a prolyl endoprotease from Eurygaster integriceps Puton (Sunn pest) infested wheat. Arch Insect Biochem Physiol. 2010; 74(3):163-78. DOI: 10.1002/arch.20370. View

19.

Cavaletti L, Taravella A, Carrano L, Carenzi G, Sigurta A, Solinas N . E40, a novel microbial protease efficiently detoxifying gluten proteins, for the dietary management of gluten intolerance. Sci Rep. 2019; 9(1):13147. PMC: 6739405. DOI: 10.1038/s41598-019-48299-7. View

20.

Stepniak D, Spaenij-Dekking L, Mitea C, Moester M, de Ru A, Baak-Pablo R . Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease. Am J Physiol Gastrointest Liver Physiol. 2006; 291(4):G621-9. DOI: 10.1152/ajpgi.00034.2006. View